In vitro activities of phenothiazine-type calmodulin antagonists against Mycobacterium leprae

Microbios

Volumn 98, Issue 390, 1999, Pages 113-121

  Dhople, Arvind M ^a  

^a Florida Institute of Technology ^*  (United States)

Author keywords

ATP; Calmodulin; Growth; Mycobacterium leprae

Indexed keywords

ACEPROMAZINE; ACETIC ACID DERIVATIVE; CALMODULIN; CHLORPROMAZINE; GLYCINE; NEUROLEPTIC AGENT; THIORIDAZINE; THYMIDINE; TRIFLUOPERAZINE;

ARTICLE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; MICROBIOLOGICAL EXAMINATION; MYCOBACTERIUM LEPRAE;

ACEPROMAZINE; ACETATES; ANTIPSYCHOTIC AGENTS; CALMODULIN; CHLORPROMAZINE; GLYCINE; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM LEPRAE; THIORIDAZINE; THYMIDINE; TRIFLUOPERAZINE;

EID: 0033257904     PISSN: 00262633     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. BALDESSARINI R. J. 1990. Drugs and the treatment of psychiatric disorders. In Goodman and Gilman's the Pharmacological Basis of Therapeutics, pp 383-435. Pergamon Press, New York.
2. BURRA S. S., Reddy P. H., Falah S. M., Venkitasubramanian T. A. and Murthy P. S. 1991. Calmodulin-like protein and the phospholipids of Mycobacterium smegmatis. FEMS Microbiol. Letters 80 189-94.
3. DHOPLE A. M. 1997. Comparative in vitro activities of rifamycin analogs against Mycobacterium leprae. Indian J. Leprosy 69 377-84.
4. DHOPLE A. M. 1998. Factors influencing in vitro growth of Mycobacterium leprae: effect of inoculum. Microbios 94 103-12.
5. DHOPLE A. M. 1999. Presence of calmodulin-like protein in Mycobacterium leprae. Biomedical Letters 59 43-7.
6. DHOPLE A. M. and Dimova V. 1996. In vitro activity of a new rifamycin derivative against Mycobacterium leprae. Arzneim. Forsch. Drug Res. 46 210-2.
7. 3H-thymidine as indicators of metabolic status and viability of Mycobacterium leprae. IRCS Med. Sci. 13 779-80.
8. 3H-thymidine to determine drug sensitivity of Mycobacterium leprae. IRCS Med. Sci. 14 807-8.
9. DHOPLE A. M. and Green K. J. 1986. Limited in vitro multiplication of Mycobacterium leprae: application to screening potential antileprosy compounds. Leprosy Rev. 57 149-62.
10. DHOPLE A. M., Green K. J. and Osborne L. J. 1988. Limited in vitro multiplication of Mycobacterium leprae. Ann. Inst. Pasteur Microbiol. 139 213-23.
11. DHOPLE A. M. and Hanks J. H. 1973. Quantitative extraction of adenosine triphosphate from cultivable and host-grown microbes: calculations of adenosine triphosphate pools. Appl. Microblol. 26 399-401.
12. DHOPLE A. M. and Ortega I. 1990. An in vitro culture method for screening new drugs against Mycobacterium leprae. Indian J. Leprosy 62 66-75.
13. DHOPLE A. M., Ortega I., Seydel J. K. and Garderner G. D. 1990. Effect of brodimoprim on Mycobacterium leprae in vitro and in mouse foot pads. Indian J. Leprosy 62 76-86.
14. FALAH A. M. S., Bhatnagar R., Bhatnagar N., Singh Y., Sidhu G. S., Murthy P. S. and Ventkitasubramanian T. A. 1988. On the presence of calmodulin-like protein in mycbacteria. FEMS Microbiol. Letters 56 89-93.
15. FOLCH J., Lees M. and Stanley G. H. S. 1957. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226 497-509.
16. GELBER R. H. 1990. Progress in chemotherapy of leprosy: status, issues and prospects. Prog. Drug Res. 34 421-45.
17. HANKS J. H., Chatterjee B. R. and Lechat M. F. 1964. A guide to the counting of mycobacteria in clinical and experimental materials. Int. J. Leprosy 32 156-67.
18. 2+-ATPase of chicken gizzard actomyosin. Biochem. biophys. Res. Commun. 90 694-9.
19. JIB. 1985. Drug resistance in leprosy. Leprosy Rev. 56 265-78.
20. KHANOLKAR S. R., Ambrose E. J., Chulawala R. G. and Bapat C. V. 1978. Autoradiographic and metabolic studies of Mycobacterium leprae. Leprosy Rev. 49 187-98.
21. NAFTALOVICH S., Yefeng E. and Eilam Y. 1991. Antitumor effects of ketaconazole and trifluoperazine in murine T cell lymphomas. Cancer Chemother. Pharmacol. 28 384-90.
22. NOORDEEN S. K., Bravo L L. and Dudaresan T. K. 1992. Estimated number of leprosy cases in the world. Bull. Wld Hlth Org. 70 7-10.
23. OCHIAI H., Kurokawa M. and Niwayama S. 1991. Influence of trifluoperazine on the late stage of influenza virus infection in MDCK cells. Antiviral Res. 15 149-60.
24. v. FEMS Microbiol. Letters 110 291-4.
25. REDDY P. H., Burra S. S. and Murthy P. S. 1992. Correlation between calmodulin-like protein, phospholipids, and growth in glucose-grown Mycobacterium phlei. Can. J. Microbiol. 38 339-42.
26. SHYU Y. T. and Foegeding P. M. 1991. Calmodulin antagonists inhibit germination of Bacillus cereus T spores. J. appl. Microbiol. 70 233-8.
27. WORLD Health Organization (WHO). 1980. Purification of Mycobacterium leprae. Annex 4 of the Fifth Meeting of the Scientific Working Group on the Immunology of Leprosy (IMMLEP), Geneva, 24-26 June. World Health Organization Document TDR/IMMLEPSWG (5)80.
28. WORLD Health Organization (WHO). 1982. Study group on chemotherapy of leprosy for control programs. World Health Organization Technical Report Series 675.